Elite Health Systems Inc.: 10-K filed 2014-04-14
What Elite Health Systems Inc. reported in its annual report filed 2014-04-14 (fiscal FY 2013): 23 published measures, 48 facts as tagged in accession 0001140361-14-016669.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-04-14
- Fiscal period
- fiscal FY 2013
- Accession
- 0001140361-14-016669 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Health Systems Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 2,080,000 | USD | |
| At 2012-12-31 | 5,293,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 679,000 | USD | |
| At 2012-12-31 | 3,225,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 1,401,000 | USD | |
| At 2012-12-31 | 2,068,000 | USD | |
| At 2011-12-31 | 1,339,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 1,414,000 | USD | |
| At 2012-12-31 | 1,450,000 | USD | |
| At 2011-12-31 | 830,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -667,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 729,000 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -980,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 861,000 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -2,271,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -431,000 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 3,215,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 190,000 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -1,777,000 | USD | |
| At 2012-12-31 | -1,110,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -362,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 362,000 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -994,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 247,000 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 1,760,000 | USD | |
| At 2012-12-31 | 5,047,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 15,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 199,000 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 679,000 | USD | |
| At 2012-12-31 | 2,863,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 0 | USD | |
| At 2012-12-31 | 7,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 994,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 1,709,000 | USD | 366 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 994,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 1,034,000 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 7,797,185 | shares | |
| At 2012-12-31 | 7,797,185 | shares |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -1,029,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 1,091,000 | USD | 366 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 0 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 414,000 | USD | 366 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | 0 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 426,000 | USD | 366 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -362,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | 362,000 | USD | 366 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-12-31 | -7,000 | USD | 365 |
| 2012-01-01 to 2012-12-31 | -306,000 | USD | 366 |
Inspect the source
- Entity
- Elite Health Systems Inc. / CIK 0001089815
- Captured
- 2026-09-20T05:21:39.780Z
- SEC response SHA-256
945f4816b81154e3435cea1e5a5dd44d20bcc6184a9c9d4e1800c05501271990
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001089815.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))